Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates episode artwork

EPISODE · Sep 14, 2025 · 23 MIN

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

from Lung Cancer Update

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Sep 14, 2025

Embed this episode

Ready to play

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

0:00 23:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Lung Cancer Update?

This episode is 23 minutes long.

When was this Lung Cancer Update episode published?

This episode was published on September 14, 2025.

Can I download this Lung Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!